BB's Stock Haven

[Bernstein]

FDA Decision THIS THURSDAY for a Drug targeting $600+ MILLION Market

(ETON) ..Market Cap $130 M / 3x FDA decisions soon : on July 11 , October 21 & May 2020 / 3x NDA expected to be submitted to FDA in second half of 2019 / has HUGE late stage pipeline with multiple near-term milestones / undiscovered Ultra low float stock = A Potential 1000% GEM and attractive takeover target ..

"EM-100. EM-100, Eton’s preservative-free ophthalmic solution for allergic conjunctivitis has been assigned a target action date of July 11, 2019. Bausch Health will be responsible for all remaining regulatory and commercial activities surrounding the product. Eton is entitled to a milestone payment upon product launch and a royalty on commercial sales."

Presentation
https://ir.etonpharma.com/static-files/202baa89-020a-44ab-8a73-d12ad27288d1

•Diversified pipeline of 11 products under development. Four products submitted to the FDA,three additional NDA’s expected to be submitted in 2019

•Expect to become commercial revenue company in 2019